Insider · CIK 0001751617
Efthymios Deliargyris
Files at CTSO (Cytosorbents Corp). First filing -, latest -.
In brief
Efthymios Deliargyris files SEC Form 4 as officer at CTSO (Cytosorbents Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Efthymios Deliargyris has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | CTSO Cytosorbents Corp | AGrant or award Common Stock | +70,000 | $0.00 | $0 | 473,025 | Aug 8, 2025 |
| Aug 8, 2025 | CTSO Cytosorbents Corp | AGrant or award Stock Option (Right to Buy)derivative | +95,000 | $0.00 | $0 | 95,000 | Aug 8, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | XIn-the-money exercise Common Stock | +16,233 | $1.00 | $16k | 403,025 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | XIn-the-money exercise Subscription Rights (right to buy)derivative | -16,233 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | JOther Series A Right Warrantsderivative | +16,233 | - | - | 16,233 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | JOther Series B Right Warrantsderivative | +16,233 | - | - | 16,233 | Jan 22, 2025 |
Questions about Efthymios Deliargyris
Answered from the filings on this page, as of the latest one.
Is Efthymios Deliargyris buying or selling?
Efthymios Deliargyris has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Efthymios Deliargyris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Efthymios Deliargyris has 0.
Where does Efthymios Deliargyris file Form 4?
Efthymios Deliargyris has filed Form 4 at CTSO (Cytosorbents Corp) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.